![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 ACS Appl Bio Mater |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Surfactant-Free Green Synthesis of Au@Chlorophyll Nanorods for NIR PDT-Elicited
CDT in Bladder Cancer Therapy.
ACS Appl Bio Mater. 2022 May 26. doi: 10.1021/acsabm.2c00228.
PubMed
Abstract available
Artificially Intelligent Olfaction for Fast and Noninvasive Diagnosis of Bladder
Cancer from Urine.
ACS Sens. 2022 May 25. doi: 10.1021/acssensors.2c00467.
PubMed
Abstract available
Transcriptional expressions of hsa-mir-183 predicted target genes as independent
indicators for prognosis in bladder urothelial carcinoma.
Aging (Albany NY). 2022;14:3782-3800.
PubMed
Abstract available
Erdafitinib for locally advanced or metastatic urothelial carcinoma.
Am J Health Syst Pharm. 2022;79:824-825.
PubMed
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers.
Am Soc Clin Oncol Educ Book. 2022;42:1-16.
PubMed
Abstract available
Yolk sac differentiation in urothelial carcinoma - A rare variant originating
from aberrant differentiation of sarcomatoid components.
Ann Diagn Pathol. 2022;58:151923.
PubMed
Abstract available
Lamprey immunity protein enables detection for bladder cancer through recognizing
N-hydroxyacetylneuraminic acid (Neu5Gc)-modified as a diagnostic marker and
exploration of its production mechanism.
Biochem Biophys Res Commun. 2022;614:153-160.
PubMed
Abstract available
Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration
and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
BMC Urol. 2022;22:79.
PubMed
Abstract available
Papillitis and uveitis complicating Bacillus Calmette-Guerin immunotherapy.
BMJ Case Rep. 2022;15.
PubMed
Abstract available
Perioperative circulating tumor DNA enables the identification of patients with
poor prognosis in upper tract urothelial carcinoma.
Cancer Sci. 2022;113:1830-1842.
PubMed
Abstract available
Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer
patients.
Cancer Sci. 2022 May 24. doi: 10.1111/cas.15438.
PubMed
Abstract available
Elevated lncRNA-UCA1 upregulates EZH2 to promote inflammatory response in
sepsis-induced pneumonia via inhibiting HOXA1.
Carcinogenesis. 2022;43:371-381.
PubMed
Abstract available
Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR
degradation and inhibiting its downstream signaling pathway to induce autophagy.
Cell Death Dis. 2022;13:499.
PubMed
Abstract available
Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via
transcriptional repression of MDR1.
Cell Death Dis. 2022;13:492.
PubMed
Abstract available
Comparative Analysis of the Efficacy of Transurethral Bipolar Plasma Needle
Electrode and Ring Electrode in the Treatment of Non-Muscle-Invasive Bladder
Cancer.
Comput Intell Neurosci. 2022;2022:6044676.
PubMed
Abstract available
New emerging targets in advanced urothelial carcinoma: Is it the primetime for
personalized medicine?
Crit Rev Oncol Hematol. 2022;174:103682.
PubMed
Abstract available
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease
management.
Crit Rev Oncol Hematol. 2022;174:103683.
PubMed
Abstract available
Re: Bladder Cancer in Patients Younger than 40 Years: Outcomes from the National
Cancer Database de la Calle CM, Washington SL 3rd, Lonergan PE, et al World J
Urol 2021;39:1911-6.
Eur Urol. 2022 May 19. pii: S0302-2838(22)01812.
PubMed
Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and
Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts.
Front Genet. 2022;13:872441.
PubMed
Abstract available
Homogeneous Polyporus Polysaccharide Inhibit Bladder Cancer by Resetting
Tumor-Associated Macrophages Toward M1 Through NF-kappaB/NLRP3 Signaling.
Front Immunol. 2022;13:839460.
PubMed
Abstract available
Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long
Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder
Cancer.
Front Oncol. 2022;12:908832.
PubMed
Abstract available
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab
maintenance treatment for advanced urothelial cancer.
Future Oncol. 2022;18:2361-2371.
PubMed
Abstract available
Erdafitinib in locally advanced/metastatic urothelial carcinoma with certain FGFR
genetic alterations.
Future Oncol. 2022;18:2455-2464.
PubMed
Abstract available
VI-RADS score system - A primer for urologists.
Int Braz J Urol. 2022;48:609-622.
PubMed
Abstract available
A brief review of the VI-RADS classification for bladder tumors on MRI (and a
call for increased interface, consistent communication and more joined studies by
the radiological and urological communities).
Int Braz J Urol. 2022;48:623-624.
PubMed
[Corrigendum] Sulforaphane suppresses the viability and metastasis, and promotes
the apoptosis of bladder cancer cells by inhibiting the expression of FAT1.
Int J Mol Med. 2022;50.
PubMed
Abstract available
Late recurrence in patients with non-muscle-invasive bladder cancer after 5-year
cancer-free periods.
Int J Urol. 2022 May 21. doi: 10.1111/iju.14936.
PubMed
Abstract available
Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and
bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer.
Int J Urol. 2022 May 22. doi: 10.1111/iju.14921.
PubMed
Abstract available
Real-world treatment patterns and clinical outcomes of Japanese patients with
non-muscle invasive bladder cancer receiving intravesical bacillus
Calmette-Guerin treatment.
Int J Urol. 2022 May 21. doi: 10.1111/iju.14933.
PubMed
Abstract available
Effects of treatments on gender differences in patients with localized
muscle-invasive bladder cancer.
Int Urol Nephrol. 2022 May 24. pii: 10.1007/s11255-022-03200.
PubMed
Abstract available
Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded
prodrug nanoparticles.
J Control Release. 2022 May 23. pii: S0168-3659(22)00302.
PubMed
Abstract available
Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients
Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A
Multicentre Cohort Analysis.
J Oncol. 2022;2022:7306198.
PubMed
Abstract available
A new approach to generating virtual samples to enhance classification accuracy
with small data-a case of bladder cancer.
Math Biosci Eng. 2022;19:6204-6233.
PubMed
Abstract available
Chondroma of the urinary bladder: A case report.
Medicine (Baltimore). 2022;101:e29229.
PubMed
Abstract available
A gender-related dichotomy in bladder cancer.
Minerva Urol Nephrol. 2022;74:376-378.
PubMed
Comment on: "Impact of the preoperative modified Glasgow Prognostic Score on
disease outcome after radical cystectomy for urothelial carcinoma of the
bladder".
Minerva Urol Nephrol. 2022;74:363-364.
PubMed
Possible role of 5-alpha reductase inhibitors in non-invasive bladder urothelial
neoplasm: multicenter study.
Minerva Urol Nephrol. 2022;74:337-343.
PubMed
Abstract available
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome
after radical cystectomy for urothelial carcinoma of the bladder.
Minerva Urol Nephrol. 2022;74:302-312.
PubMed
Abstract available
Urethral fixation technique improves urinary continence recovery in men
undergoing open radical cystectomy and ileal orthotopic neobladder.
Minerva Urol Nephrol. 2022;74:313-320.
PubMed
Abstract available
Is adjuvant immunotherapy effective in patients with urothelial cancer?
Minerva Urol Nephrol. 2022;74:252-254.
PubMed
Coexisting of myasthenia gravis and fulminant myocarditis induced by nivolumab in
a patient with ureteral epithelial cancer.
Neuro Endocrinol Lett. 2021;42:383-386.
PubMed
Abstract available
Variables affecting quality of life after Radical cystectomy and neobladder
substitution: Egyptian National Cancer Institute experience.
Prog Urol. 2022;32:410-418.
PubMed
Abstract available
Perioperative results of radical cystectomy after neoadjuvant chemotherapy
according to the implementation of ERAS pathway.
Prog Urol. 2022;32:401-409.
PubMed
Abstract available
Standardized care pathway for bladder cancer in Sweden. So far lots of pain but
little gain.
Scand J Urol. 2022 May 23:1-2. doi: 10.1080/21681805.2022.2078876.
PubMed
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in
bladder cancer promotes sensitivity to gemcitabine.
Sci Rep. 2022;12:8535.
PubMed
Abstract available
Spectrochim Acta A Mol Biomol Spectrosc
Label-free detection of bladder cancer and kidney cancer plasma based on SERS and
multivariate statistical algorithm.
Spectrochim Acta A Mol Biomol Spectrosc. 2022;279:121336.
PubMed
Abstract available
In Utero Exposure to 3,3',4,4', 5-Pentachlorobiphenyl Dose-Dependently Induces
N-butyl-4-(hydroxybutyl) Nitrosamine in Rats With Urinary Bladder Carcinoma.
Toxicol Pathol. 2022;50:366-380.
PubMed
Abstract available
Chronic kidney disease and radical cystectomy for bladder cancer: perioperative
and oncologic outcomes in 1,214 patients.
Urol Oncol. 2022 May 19. pii: S1078-1439(22)00121.
PubMed
Abstract available
Metastatic urothelial carcinoma of the urinary bladder in a Sumatran tiger
(Panthera tigris sondaica).
Vet Med Sci. 2022;8:1288-1293.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by